심장이식 환자에서 Cyclosporine에 의한 중추신경독성 -1례 보고-

Cyclosporine-Assoc iated Central Neurotox ic its after Hearat Transplantat ion 1 Case Report

  • 김용희 (아산재단 서울중앙병원 울산대학교 외과대학 흉부외과) ;
  • 송현 (아산재단 서울중앙병원 울산대학교 외과대학 흉부외과) ;
  • 송명근 (아산재단 서울중앙병원 울산대학교 외과대학 흉부외과)
  • Kim, Young-Hee (Department of Thoracic and Cardiovascular Surgery, College of Medicine, University of Ulsan, Asan Medical Center) ;
  • Song, Hyun (Department of Thoracic and Cardiovascular Surgery, College of Medicine, University of Ulsan, Asan Medical Center) ;
  • Song, Meong-Gun (Department of Thoracic and Cardiovascular Surgery, College of Medicine, University of Ulsan, Asan Medical Center)
  • 발행 : 1997.11.01

초록

승모판막 폐쇄부전증으로 승모판막 치환술을 받은 45세 남자가 확장성 심근증으로 심장이식수술을 받았다. 환자는 수술전 면역억제를 위하여 cyclosporine 400 mg, Immuran 250 mg과 Solumedrol 500 mg을 투약하였 다 술후 cyclosporine을 2 mg/kg/day로 정주했는데 술후 8시간이 지나도 혼수상태가 지속되어 cyclosporine을 1 mg/kg/day로 감량하였다. 당시 혈장내 cyclosporine농도는 345$\mu\textrm{g}$/L, 크레아티닌 수치는 1.8 mg/dl였으며 마그 네슘 수치는 정상수준이 였다. 환자의 의식은 술후 31시간째 완전히 회복되었으나 술후 36시간경부터 전신근 력약화, 초조감, 환청 및 환각을 호소하였다. 신경증상들은 술후 4일째 정상으로 회복되었으며, 환자는 술후 28일째 퇴원하였고 12개월째 후유증은 보이지 않고 있다.

A 45-year-old man underwent heart transplantation due to dilated cardiomyopathy. Cyclosporine, 2 mg/kg per day, was intravenously givell postoperatively. As central neurotoxicity signs that were included pin-point pupil, no light reflex, coma, were presented at 8 postoperative hours, cyclosporine was decreased to 1 mg/kg er day. At that time the cyclosporine level was 345 $\mu\textrm{g}$/L, the serum creatinine level was 1.8mg/dl and the serum magnesium level was within normal limit. He awaked at 31 postoperative hours and all sign of cyclosporine-induced central neurotoxicity was resolved after postoperative days. He was discharged without sequale at postoperative day 28.

키워드

참고문헌

  1. J Pharmacol Exp Ther v.268 no.2 Potential Neuro- toxicity of the Solvent Vehicle for Cyclosporine Windebank AJ;Blexrud MD;De Groen PC
  2. Transplantation v.61 no.4 Central Pontine Myelinoysis and Cyclosporine Neurotoxicity Following Liver Transplantatin Fryer JP;Fortier MV;Metrakos P(et al)
  3. N Engl J Med v.317 no.14 Central Nervous System Toxicity after Liver Transplantation DeGroen PC;Akasmit AJ;Rakela J
  4. Lancet v.Nov no.17 Asso- ciated Between Cyclosporine Neurotoxicity and Hypoma- gnesaemia Thomson CB;June CH;Sullivan KM;Thomas ED
  5. Transplantation v.58 no.2 Neurotoxicity after Orthotopic Liver Transplantation Mueller AR;Platz KP;Bechstein WO(et al)
  6. Trans- plantation v.38 no.1 Cyclosporine-Associated Central Nervous System Toxicity after Allogenic Bone Marrow Transplantation Atkinson K;Biggs J;Darveniza P;Boland J;Concannon A;Dodds A
  7. Ann Thorac Surg v.52 Cyclosporine-Associated Central Neurotoxicity After Heart Transplantatuion McManus RP;O'Hair DP;Schweiger J;Beitzinger J;Siegel R
  8. Pediatr Radiol v.25 Cyclosporine A toxicity:MRI appearance of the brain Pace MT;Slovis TL;Kelly JK;Abella SD